Studies involving disease:Inflammatory bowel disease
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human | Vanderbilt University Medical Center |
| ST000923 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Human | Broad Institute of MIT and Harvard |
| ST001125 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacteroides ovatus | Broad Institute of MIT and Harvard |
| ST001125 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacteroides thetaiotaomicron | Broad Institute of MIT and Harvard |
| ST001126 | WT and ΔSPT cultures of B. thetaiotaomicron grown in Minimal Media (part II) | Bacteroides thetaiotaomicron | Broad Institute of MIT and Harvard |
| ST003161 | Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort | Human | Sheba hospital |
| ST003312 | Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - serum | Human | Sheba hospital |
| ST003313 | Integrative analysis of serum and fecal metabolome and the microbiome that herald Crohn Disease flare - feces | Human | Sheba hospital |
| ST003361 | Bile acid–induced gut mitochondrial dysfunction promotes Enterobacteriaceae colonization and associates with dysbiosis in Crohn's disease | Mouse | University of British Columbia |
| ST003481 | Therapeutic potential of galactooligosachaccharides and Lactobacillus reuteri supplementation on dextran sulfate sodium-induced gut inflammation | Mouse | China Agricultural University |
| ST003561 | High serum pesticide levels are associated with increased odds of inflammatory bowel disease in a nested case-control study | Human | Mount Sinai |
| ST003910 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bifidobacteria | Broad Institute of MIT and Harvard |
| ST003910 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Clostridium | Broad Institute of MIT and Harvard |
| ST003910 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Escherichia coli | Broad Institute of MIT and Harvard |
| ST003910 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Streptococcus | Broad Institute of MIT and Harvard |
| ST003911 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Eggerthella lenta | Broad Institute of MIT and Harvard |
| ST003911 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Fusobacterium nucleatum | Broad Institute of MIT and Harvard |
| ST003930 | Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-pos profiling of mouse fecal samples | Mouse | Broad Institute of MIT and Harvard |
| ST003931 | Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-neg, C8-pos and C18-neg profiling of mouse fecal samples | Mouse | Broad Institute of MIT and Harvard |
| ST003954 | Integrated analysis of irritable bowel syndrome comorbid with psychological disorders based on microbiomics and metabolomics | Human | Sun Yat-sen University |
